Sun Pharma and US-based Pharmazz to introduce cerebral ischemic stroke drug in India, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

Under the terms of the agreement, Sun Pharma has been granted the rights to market Sovateltide in India using the brand name Tyvalzi™ (Sovateltide). In return, Pharmazz will receive upfront payments, milestone payments, and royalties as stipulated in the agreement., Under the terms of the agreement, Sun Pharma has been granted the rights to market Sovateltide in India using the brand name Tyvalzi™ (Sovateltide). In return, Pharmazz will receive upfront payments, milestone payments, and royalties as stipulated in the agreement., , Read More

Leave a Reply

Your email address will not be published.